A NOMOGRAM FOR PREDICTING OPTIMAL DOSAGE OF CYCLOSPORINE RENAL-TRANSPLANT PATIENTS - TAKING PHYSIOLOGICAL FACTORS INTO CONSIDERATION FOR REGIMEN DURING IMMUNOSUPPRESSIVE THERAPY
N. Shibata et al., A NOMOGRAM FOR PREDICTING OPTIMAL DOSAGE OF CYCLOSPORINE RENAL-TRANSPLANT PATIENTS - TAKING PHYSIOLOGICAL FACTORS INTO CONSIDERATION FOR REGIMEN DURING IMMUNOSUPPRESSIVE THERAPY, Biological & pharmaceutical bulletin, 18(10), 1995, pp. 1423-1429
We constructed a nomogram for determining the optimal regimen of cyclo
sporine (CyA), based on physiological changes that occur during immuno
suppressive therapy. The nomogram consists of a fixed model and a vari
able model. In the fixed model, the oral dose of CyA (D, mg/kg) is giv
en by the multiple linear function of logarithmic CyA trough level (TL
, ng/ml), the surrogate apparent total body clearance of CyA (CL/f(su)
, 1/h/kg, being equal to D/TL/12), and the erythrocyte-to-plasma distr
ibution ratio of CyA (CyA-EP), as defined by: D = 4.938 x log(TL)+ 1.5
037 x CL/f(su) - 0.0326 x CyA-EP - 10.7156. In the variable model, the
CL/f(su) is given by the CYA-EP and the patient's intrinsic parameter
s (P-1, P-2), using a nonlinear equation: CL/f(su) = P-1 x exp(P-2 x C
yA-EP)/CyA-EP. An optimal CyA dose to maintain a desired trough level
was calculated, and the validity of the nomogram was found satisfactor
y for clinical use. This offers a very concise and practical method fo
r the therapeutic monitoring of CyA. Because the pharmacokinetics of C
yA depends on physiological changes due to several disease states, and
because the CyA-EP reflects the pharmacokinetics of CyA and the patie
nt's disease state, the proposed nomogram is believed to provide an op
timal dosage adjustment, taking physiological factors into considerati
on.